By comparing and contrasting ALS gene expression changes to distinct models of inflammatory reactive astrocytes, including the A1 (TNF, IL1A, and C1q treated) and protective (MCAO, SCI) data sets, we reveal widespread changes that correspond with inflammatory reactive gene expression and signaling pathway activity (Fig. 5). The gene discussed is TNF; the disease is amyotrophic lateral sclerosis.